RaySearch Laboratories (Q2 Initial take): Confidence in a strong H2 - Redeye
Bildkälla: Stockfoto

RaySearch Laboratories (Q2 Initial take): Confidence in a strong H2 - Redeye

RaySearch’s Q2 figures were largely known following the July profit warning. More importantly, management reiterates its full-year EBIT margin target of +25%, while the recently announced US orders provide a strong signal that the Q2 delays were indeed timing related. We continue to expect a significantly stronger H2 2026.

RaySearch’s Q2 figures were largely known following the July profit warning. More importantly, management reiterates its full-year EBIT margin target of +25%, while the recently announced US orders provide a strong signal that the Q2 delays were indeed timing related. We continue to expect a significantly stronger H2 2026.
Börsvärldens nyhetsbrev